Is 4D Molecular Therapeutics Inc (NASDAQ: FDMT) Back In The Buying Zone?
Currently, there are 42.75M common shares owned by the public and among those 36.60M shares have been available to trade. Insiders at the company have transacted a total of 17 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 8 of these insider trades were purchases, […]
4D Molecular Therapeutics Inc (FDMT): Street Finally Waking Up
RA Capital Management LP recently announced the acquisition of new stake in 4D Molecular Therapeutics Inc (NASDAQ:FDMT). The institutional investor has increased its shareholding in the Healthcare company by 35.63% to 4.16 million shares with purchase of 1.09 million shares. This fresh investment now brings its stake to 9.74% valued currently at $52.96 million. In […]
